Assessment of outcomes and differences between in-and out-of-hospital cardiac arrest patients treated with cardiopulmonary resuscitation using extracorporeal life support E Kagawa, I Inoue, T Kawagoe, M Ishihara, Y Shimatani, S Kurisu, ... Resuscitation 81 (8), 968-973, 2010 | 307 | 2010 |
Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus K Nakamura, T Miyoshi, M Yoshida, S Akagi, Y Saito, K Ejiri, N Matsuo, ... International journal of molecular sciences 23 (7), 3587, 2022 | 106 | 2022 |
Vascular injury is a major cause of lung injury after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension K Ejiri, A Ogawa, S Fujii, H Ito, H Matsubara Circulation: Cardiovascular Interventions 11 (12), e005884, 2018 | 88 | 2018 |
Long-term patient survival with idiopathic/heritable pulmonary arterial hypertension treated at a single center in Japan A Ogawa, K Ejiri, H Matsubara Life sciences 118 (2), 414-419, 2014 | 87 | 2014 |
Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a … K Ichikawa, T Miyoshi, K Osawa, T Miki, H Toda, K Ejiri, M Yoshida, ... Cardiovascular diabetology 20, 1-10, 2021 | 44 | 2021 |
Effect of luseogliflozin on heart failure with preserved ejection fraction in patients with diabetes mellitus K Ejiri, T Miyoshi, H Kihara, Y Hata, T Nagano, A Takaishi, H Toda, ... Journal of the American Heart association 9 (16), e015103, 2020 | 44 | 2020 |
Usefulness of lipoprotein (a) for predicting progression of non-culprit coronary lesions after acute myocardial infarction H Ikenaga, M Ishihara, I Inoue, T Kawagoe, Y Shimatani, F Miura, ... Circulation Journal 75 (12), 2847-2852, 2011 | 40 | 2011 |
Bail-out technique for pulmonary artery rupture with a covered stent in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension K Ejiri, A Ogawa, H Matsubara JACC: Cardiovascular Interventions 8 (5), 752-753, 2015 | 39 | 2015 |
Who benefits most from mild therapeutic hypothermia in coronary intervention era? A retrospective and propensity-matched study E Kagawa, I Inoue, T Kawagoe, M Ishihara, Y Shimatani, S Kurisu, ... Critical Care 14, 1-12, 2010 | 34 | 2010 |
Epoprostenol sodium for treatment of pulmonary arterial hypertension Y Saito, K Nakamura, S Akagi, T Sarashina, K Ejiri, A Miura, A Ogawa, ... Vascular health and risk management, 265-270, 2015 | 33 | 2015 |
Incremental prognostic value of non-alcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease K Ichikawa, T Miyoshi, K Osawa, T Miki, H Toda, K Ejiri, M Yoshida, ... European Journal of Preventive Cardiology 28 (18), 2059-2066, 2021 | 30 | 2021 |
Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension K Nakamura, M Sakaguchi, H Matsubara, S Akagi, T Sarashina, K Ejiri, ... PLoS One 13 (9), e0203046, 2018 | 30 | 2018 |
Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized … T Miyoshi, K Ejiri, K Kohno, M Nakahama, M Doi, M Munemasa, ... International Journal of Cardiology 236, 36-42, 2017 | 30 | 2017 |
Nanoparticle-mediated drug delivery system for pulmonary arterial hypertension K Nakamura, H Matsubara, S Akagi, T Sarashina, K Ejiri, N Kawakita, ... Journal of Clinical Medicine 6 (5), 48, 2017 | 29 | 2017 |
Antithrombotic strategy for patients with acute coronary syndrome: a perspective from East Asia Y Numasawa, M Sawano, R Fukuoka, K Ejiri, T Kuno, S Shoji, S Kohsaka Journal of Clinical Medicine 9 (6), 1963, 2020 | 24 | 2020 |
Current treatment strategies and nanoparticle-mediated drug delivery systems for pulmonary arterial hypertension K Nakamura, S Akagi, K Ejiri, M Yoshida, T Miyoshi, N Toh, K Nakagawa, ... International journal of molecular sciences 20 (23), 5885, 2019 | 24 | 2019 |
Reverse right ventricular remodeling after lung transplantation in patients with pulmonary arterial hypertension under combination therapy of targeted medical drugs T Sarashina, K Nakamura, S Akagi, T Oto, H Oe, K Ejiri, K Nakagawa, ... Circulation Journal 81 (3), 383-390, 2017 | 23 | 2017 |
Higher oxidized high-density lipoprotein to apolipoprotein AI ratio is associated with high-risk coronary plaque characteristics determined by CT angiography K Suruga, T Miyoshi, K Kotani, K Ichikawa, T Miki, K Osawa, K Ejiri, ... International Journal of Cardiology 324, 193-198, 2021 | 18 | 2021 |
Effects of bisoprolol transdermal patches for prevention of perioperative myocardial injury in high-risk patients undergoing non-cardiac surgery―multicenter randomized … H Toda, K Nakamura, K Shimizu, K Ejiri, T Iwano, T Miyoshi, K Nakagawa, ... Circulation Journal 84 (4), 642-649, 2020 | 17 | 2020 |
Effects of luseogliflozin and voglibose on high-risk lipid profiles and inflammatory markers in diabetes patients with heart failure K Ejiri, T Miyoshi, H Kihara, Y Hata, T Nagano, A Takaishi, H Toda, ... Scientific reports 12 (1), 15449, 2022 | 15 | 2022 |